
Clever Collaboration: Atossa Therapeutics and Karolinska Institute to Discuss Preventing Breast Cancer at BIO EUROPE 2024
Atossa Therapeutics Announces Participation in BIO-Europe 2024 Join our CEO for a Fireside Chat on Breast Cancer Prevention SEATTLE, Oct. 21, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ: ATOS) (“Atossa” or the “Company”), today announced that Steven Quay, M.D., Ph.D., Chairman and Chief Executive Officer, will join Per Hall, M.D., Professor of Epidemiology at…